Financial Times/Deloitte Pharmaceutical & Biotechnology Conference 2014

Predictions 2020: The future of the industry

One of the most pre-eminent global life sciences industry events attended by leading executives, government decision makers, investors, analysts and other specialist providers. It provides a unique platform to present new perspectives, share insights, discuss the industry's future and network with peers across the industry.

17-18 November 2014 | Marriott Grosvenor | London

The future is arriving fast for the life science industry. Convergence is happening along the entirety of the industry value chain, blurring the boundaries between pharma, biotech, genetics, devices and broader healthcare companies. Advanced technologies and materials, once the realm of science fiction, are now starting to emerge and can be expected to play a much greater role in the research efforts of life science companies in the future. Emerging market companies are expanding and edging their way to the top table as innovator drug companies. What will the life science company of the future look like? How will the industry be transformed?


Confirmed speakers

  • Joseph Jimenez, Chief Executive Officer, Novartis
  • Flemming Ornskov, Chief Executive Officer, Shire
  • Rob ten Hoedt, Executive Vice President and President, EMEA & Canada, Medtronic, Chairman, Eucomed
  • Brent Saunders, CEO and President, Actavis
  • Bahija Jallal, Executive Vice President,AstraZeneca, Head of MedImmune
  • Christian Hogg, Chief Executive Officer, Hutchison China MedTech Limited
  • Stefan Oschmann, Member of the Executive Board, CEO Pharma, Merck
  • Professor Guido Rasi, Executive Director, European Medicines Agency (EMA)
  • Sir Andrew Dillon, Chief Executive, National Institute for Health and Care Excellence (NICE)
  • Simon Stevens, Chief Executive, NHS England
  • Dr Diego Miralles, Global Head, Innovation, Janssen
  • Michael Doherty, Global Head, Pharma Regulatory Affairs, Hoffmann La- Roche
  • Glen de Vries, President, Medidata 
  • Professor Ian Goldin, Director, Oxford Martin School, University of Oxford
  • Peter Grant, Chief Executive Officer, Skyepharma
  • Dr Mikael Dolsten, President of Worldwide Research and Development, Pfizer
  • Dr Julie Gerberding, President, Vaccines, Merck & Co, Inc
  • Walter Capone, President, Multiple Myeloma Research Foundation
  • John Reed, Head of Pharma Research & Early Development, Hoffmann La-Roche
  • Reynold W. (Pete) Mooney, Global Leader, Life Sciences and Health Care, Deloitte Touche Tohmatsu
  • Earl Howe, Parliamentary Under-Secretary of State for Quality, Department of Health, UK
  • Kofi Amegashie, Managing Executive - Africa, Adcock Ingram Healthcare
  • Wim Leereveld, Chief Executive Officer and Founder, The Access to Medicine Index
  • Dr Diego Miralles, Global Head, Innovation, Janssen
  • Hanno Ronte, Health Care & Life Sciences Partner, Monitor Deloitte
  • Professor Christofer Toumazou, Founder and Chief Scientist, Institute of Biomedical Engineering, Imperial College
  • Daniel Mahony, Fund Manager-Healthcare, Polar Capital
  • J.P Errico,Chairman, Founder, Principal Investor and CFO, electoCore Medical

Visit the Conference website to learn more about the speakers, agenda, topics to be covered and to register. Please use marketing code DEL35 to receive 35% off the current registration rate.